More

    Exclusive: Biotech startup Profluent says it has found “scaling laws” for AI models for protein design



    [

    Illustration of a large DNA helix and a pair of tweezers holding a small DNA segment that is about to be inserted into the helix.

    A photo illustration depicting gene editing. Using its new ProGen3 AI model, biotech startup Profluent has developed new gene editing proteins that may be more effective than the CRISPR-Cas9 systems that underpin most contemporary gene editing therapies.

    Photo illustration—Getty Images

    https://fortune.com/img-assets/wp-content/uploads/2025/04/GettyImages-1359391658_89f21f-e1744742272513.jpg?resize=1200,600
    https://fortune.com/2025/04/16/biotech-profluent-ai-scaling-laws-protein-design-models-opencrispr-openantibodies/


    Jeremy Kahn

    Latest articles

    spot_imgspot_img

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here

    spot_imgspot_img